SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 3 - Initial statement of beneficial ownership of securities:
SEC Accession No. 0001209191-23-045710
Filing Date
2023-08-14
Accepted
2023-08-14 19:02:55
Documents
2
Period of Report
2023-08-10

Document Format Files

Seq Description Document Type Size
1 FORM 3 SUBMISSION doc3.html 3  
1 FORM 3 SUBMISSION doc3.xml 3 4597
2 POA DOCUMENT poa.txt EX-24 3128
  Complete submission text file 0001209191-23-045710.txt   9175
Mailing Address C/O NEVRO CORP. 1800 BRIDGE PARKWAY REDWOOD CITY CA 94065
Business Address
Alecxih James (Reporting) CIK: 0001725232 (see all company filings)

Type: 3 | Act: 34 | File No.: 001-39813 | Film No.: 231172670

Mailing Address 6272 WEST 91ST AVENUE WESTMINSTER CO 80031
Business Address 6272 WEST 91ST AVENUE WESTMINSTER CO 80031 415 336 8917
TriSalus Life Sciences, Inc. (Issuer) CIK: 0001826667 (see all company filings)

IRS No.: 853009869 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 8071 Services-Medical Laboratories